Munde Manoj, Ismail Mohamed A, Arafa Reem, Peixoto Paul, Collar Catharine J, Liu Yang, Hu Laixing, David-Cordonnier Marie-Hélène, Lansiaux Amélie, Bailly Christian, Boykin David W, Wilson W David
Department of Chemistry, Georgia State University, P.O. Box 4098, Atlanta, GA 30302-4098, USA.
J Am Chem Soc. 2007 Nov 7;129(44):13732-43. doi: 10.1021/ja074560a. Epub 2007 Oct 13.
The classical model of DNA minor groove binding compounds is that they should have a crescent shape that closely fits the helical twist of the groove. Several compounds with relatively linear shape and large dihedral twist, however, have been found recently to bind strongly to the minor groove. These observations raise the question of how far the curvature requirement could be relaxed. As an initial step in experimental analysis of this question, a linear triphenyl diamidine, DB1111, and a series of nitrogen tricyclic analogues were prepared. The goal with the heterocycles is to design GC binding selectivity into heterocyclic compounds that can get into cells and exert biological effects. The compounds have a zero radius of curvature from amidine carbon to amidine carbon but a significant dihedral twist across the tricyclic and amidine-ring junctions. They would not be expected to bind well to the DNA minor groove by shape-matching criteria. Detailed DNase I footprinting studies of the sequence specificity of this set of diamidines indicated that a pyrimidine heterocyclic derivative, DB1242, binds specifically to a GC-rich sequence, -GCTCG-. It binds to the GC sequence more strongly than to the usual AT recognition sequences for curved minor groove agents. Other similar derivatives did not exhibit the GC specificity. Biosensor-surface plasmon resonance and isothermal titration calorimetry experiments indicate that DB1242 binds to the GC sequence as a highly cooperative stacked dimer. Circular dichroism results indicate that the compound binds in the minor groove. Molecular modeling studies support a minor groove complex and provide an inter-compound and compound-DNA hydrogen-bonding rational for the unusual GC binding specificity and the requirement for a pyrimidine heterocycle. This compound represents a new direction in the development of DNA sequence-specific agents, and it is the first non-polyamide, synthetic compound to specifically recognize a DNA sequence with a majority of GC base pairs.
DNA小沟结合化合物的经典模型是,它们应具有新月形,能紧密契合小沟的螺旋扭曲。然而,最近发现几种形状相对呈线性且二面角扭曲较大的化合物能与小沟强烈结合。这些观察结果提出了一个问题,即对曲率的要求可以放宽到何种程度。作为对该问题进行实验分析的第一步,制备了一种线性三苯基二脒DB1111和一系列氮杂三环类似物。对于这些杂环化合物的目标是,将GC结合选择性设计到能够进入细胞并发挥生物学效应的杂环化合物中。这些化合物从脒基碳到脒基碳的曲率半径为零,但在三环和脒环连接处有显著的二面角扭曲。根据形状匹配标准,预计它们不会很好地与DNA小沟结合。对这组二脒的序列特异性进行的详细DNase I足迹研究表明,一种嘧啶杂环衍生物DB1242能特异性结合富含GC的序列-GCTCG-。它与GC序列的结合比与弯曲小沟剂通常识别的AT序列更强。其他类似衍生物未表现出GC特异性。生物传感器表面等离子体共振和等温滴定量热法实验表明,DB1242以高度协同的堆叠二聚体形式结合到GC序列上。圆二色性结果表明该化合物在小沟中结合。分子模拟研究支持形成小沟复合物,并为异常的GC结合特异性以及对嘧啶杂环的要求提供了化合物间和化合物与DNA之间氢键的原理。该化合物代表了DNA序列特异性试剂开发的一个新方向,并且是第一个特异性识别具有大多数GC碱基对的DNA序列的非聚酰胺合成化合物。